||Registry of biomedical companies:
   [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Z] 537 active entries
Kosmonavta Volkova 6a-1205
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
GERO (ex Quantum Pharmaceuticals) is a drug discovery company designing first in class small molecule therapeutics using proprietary, industry leading molecular modeling and systems biology technologies.
Since being established in 2004, the company has developed a portfolio of preclinical, first in class small molecules against high-interest targets in cancer metabolism, diabetes, and neuroprotection.
Recently, our focus has turned to developing new medicines to combat the aging process and extend healthy human lifespans. We have developed new insights into aging biology, primarily around the stability and stress resistance of certain gene regulatory networks 1.
- Our research has revealed new druggable targets which we believe will translate into innovative medicines to delay a number of age related diseases, including human frailty and mortality itself . By combining our powerful molecular modelling capabilities with our insights into the biology of important new drug targets, we are developing a portfolio of new medicines which delay human mortality while maintaining a high quality of life.
Last update of this entry: August 06, 2015